Evidence map›Paper›PMID 35517818›Full record

ArticleFrontiers in pharmacology2022

A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn's Disease.

Kai Nie, Chao Zhang, Minzi Deng, Weiwei Luo, Kejia Ma, Jiahao Xu, Xing Wu, Yuanyuan Yang, Xiaoyan Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kai NieDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Chao ZhangDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Minzi DengDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Weiwei LuoDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Kejia MaDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Jiahao XuDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Xing WuDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Yuanyuan YangDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Xiaoyan WangDepartment of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China.
Central South University · CNThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antitumor necrosis factor α therapyCrohn’s diseasedifferentially expressed genesdrug responsehub genes

Identifiers

PMID35517818
PMCPMC9065476
OpenAlexW4224242603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.